Freund : Results of Operations for the Fiscal Year Ended February 28, 2022
April 26, 2022
Share
FREUND CORPORATION
(Securities code: 6312)
Results of Operations for the Fiscal Year Ended February 28, 2022
April 27, 2022
Copyright(C) 2022 Freund Corp. All rights reserved.
Contents
Consolidated Financial Summary for FY2/22
・・・
P.02
Consolidated Earnings and Dividend Forecasts for FY2/23
・・・
P.16
Medium‐term Management Plan
・・・ P.20
Supplementary Materials
・・・
P.25
Factsheet
・・・
Appendix
Copyright (C) 2022 Freund Corp. All rights reserved.
1
Consolidated Financial Summary for FY2/22
Copyright(C) 2022 Freund Corp. All rights reserved.
Consolidated Financial Summary
Sales increased and earnings decreased YoY.
Domestic sales were favorable, but performance was severely impacted by shipment delays due to component procurement difficulties at overseas subsidiaries.
Although profit declined in nominal terms, operating profit and ordinary profit in real terms were higher than in the previous year after adjusting the previous year's one-time gain at the U.S. subsidiary of approx. 300 million yen (subsidy of approx. 200 million yen and insurance income of approx. 100 million yen).
Big profit decline due to an extraordinary loss of approx. 200 million yen.
(Millions of yen)
FY2/21
FY2/22
YoY change
Forecast
Amount
％
Net sales
16,765
17,632
+866
+5.2%
18,500
Operating profit
1,111
981
(129)
(11.6)%
1,100
Ordinary profit
1,308
1,032
(275)
(21.1)%
1,130
Profit
970
543
(427)
(44.0)%
790
Earnings per share (yen)
57.96
32.46
(25.50)
-
47.18
Orders received
12,386
15,621
+3,234
+26.1%
-
Order backlog
6,615
10,574
+3,958
+59.8%
-
Capital investment
637
571
(65)
(10.3)%
-
Depreciation
461
570
+108
+23.5%
-
R&D expenses
526
580
+53
+10.2%
-
ROA
4.7%
2.4%
-
-
-
ROE
7.2%
3.9%
-
-
-
3
Copyright (C) 2022 Freund Corp. All rights reserved.
Machinery Business: Overview
Net Sales
Net sales increased due to the full-year contribution of Cos.Mec (only Q4 results were consolidated in the previous fiscal year).
Domestic sales were favorable. Overseas sales were severely impacted by tight supplies of components.
Operating Profit
Operating profit declined due to sluggish performance of overseas subsidiaries.
Orders Received/Order Backlog
Orders at overseas subsidiaries are strong. There is demand for major capital investments in the generic drug industry in Japan.
Record high consolidated order backlog (FY2/22 consolidated orders received were the second highest ever).
(Millions of yen)
FY2/21
FY2/22
Amount
YoY change (%)
Amount
YoY change (%)
Net sales
11,171
+0.5
11,836
+6.0
Operating profit
1,047
+236.8
623
(40.5)
Orders received
12,386
+21.1
15,621
+26.1
Order backlog
6,615
+40.9
10,574
+59.8
Copyright (C) 2022 Freund Corp. All rights reserved.
4
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Freund Corporation published this content on 27 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2022 08:44:00 UTC.
Freund Corporation is a Japan-based company primarily engaged in the manufacture and sale of machinery and chemical products. The Company operates through two business segments. The Machinery segment is engaged in the manufacture and sale of powder and granular machinery, measuring instrument and components, the construction of granular machinery plants, as well as the contracted manufacture of fine grinding of synthetic resin. The Chemical Product segment is involved in the manufacture and sale of pharmaceutical excipients and nutritious supplements, the manufacture of food preservatives, the development and research of pharmaceuticals, food and chemicals, the review of prescriptions, the contacted manufacture and brokerage of study drugs, as well as the development and technology licensing of new dosage forms.
FREUND CORPORATION 
